Amy R. Leslie

Olaparib-Induced Senescence Is Bypassed through G2–M Checkpoint Override in Olaparib-Resistant Prostate Cancer

Alan P. Lombard, Cameron M. Armstrong, Leandro S. D’Abronzo et al. · Molecular Cancer Therapeutics · 2022 · 23 citations · Full text

Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment

Shu Ning, Chengfei Liu, Wei Lou et al. · Molecular Cancer Therapeutics · 2022 · 21 citations · Full text

Urology, Enhances Enzalutamide Treatment, Enzalutamide Resistance +13

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes

Shu Ning, Jinge Zhao, Alan P. Lombard et al. · Communications Medicine · 2022 · 10 citations · Full text

IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer

Amy R. Leslie, Shu Ning, Cameron M. Armstrong et al. · iScience · 2024 · 10 citations · Full text